700138P
7-dehydrodesmosterol
Manufacturer: Sigma Aldrich
CAS Number: 1715-86-2
Synonym(S): Cholesta-5,7,24-trien-3β-ol
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 700138P-1-MG | In Stock | ₹ 1,07,589.68 |
700138P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 1,07,589.68
GST (18%): ₹ 19,366.142
Total Price: ₹ 1,26,955.822
form
powder
packaging
pkg of 1 × 1 mg (700138P-1mg)
manufacturer/tradename
Avanti Polar Lipids 700138P
shipped in
dry ice
storage temp.
−70°C
InChI
1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
InChI key
RUSSPKPUXDSHNC-DDPQNLDTSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 1715-86-2 | Cholesta-5,7,24-trien-3-ol,(3b)- | A2B Chem | ₹ 1,26,885.48 |
Related Products
Description
- General description: 7-dehydrodesmosterol (7-DHD) is synthesized via the Bloch pathway. 7-DHD serves as a desmosterol synthesis precursor and the enzyme 7-dehydrocholesterol reductase (DHCR7) catalyzes this step.[1]
- Application: 7-dehydrodesmosterol has been used as an internal oxysterol standard in ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).[2]
- Biochem/physiol Actions: 7-dehydrodesmosterol (7-DHD) levels are higher during fetal development[3] and increases with aging.[4] Elevated levels of 7-DHD is associated with Smith-Lemli-Opitz syndrome mouse model.[3] Reduced levels of 7-DHD is observed in shiverer and quaking disorder.[5]
- Packaging: 5 mL Amber Glass Screw Cap Vial (700138P-1mg)
Compare Similar Items
Show Difference
form: powder
packaging: pkg of 1 × 1 mg (700138P-1mg)
manufacturer/tradename: Avanti Polar Lipids 700138P
shipped in: dry ice
storage temp.: −70°C
InChI: 1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
InChI key: RUSSPKPUXDSHNC-DDPQNLDTSA-N
form:
powder
packaging:
pkg of 1 × 1 mg (700138P-1mg)
manufacturer/tradename:
Avanti Polar Lipids 700138P
shipped in:
dry ice
storage temp.:
−70°C
InChI:
1S/C27H42O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9-10,19,21,23-25,28H,6,8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
InChI key:
RUSSPKPUXDSHNC-DDPQNLDTSA-N
form: __
packaging: __
manufacturer/tradename: Novagen®
shipped in: dry ice
storage temp.: −70°C
InChI: __
InChI key: __
form:
__
packaging:
__
manufacturer/tradename:
Novagen®
shipped in:
dry ice
storage temp.:
−70°C
InChI:
__
InChI key:
__
form: powder
packaging: pkg of 1 × 50 mg (700142P-50mg)
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1
InChI key: ORNBQBCIOKFOEO-QGVNFLHTSA-N
form:
powder
packaging:
pkg of 1 × 50 mg (700142P-50mg)
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C
InChI:
1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1
InChI key:
ORNBQBCIOKFOEO-QGVNFLHTSA-N
form: powder
packaging: pkg of 1 × 10 mg (700149P-10mg)pkg of 1 × 25 mg (700149P-25mg)
manufacturer/tradename: Avanti Polar Lipids 700149P
shipped in: dry ice
storage temp.: −20°C
InChI: __
InChI key: __
form:
powder
packaging:
pkg of 1 × 10 mg (700149P-10mg)pkg of 1 × 25 mg (700149P-25mg)
manufacturer/tradename:
Avanti Polar Lipids 700149P
shipped in:
dry ice
storage temp.:
−20°C
InChI:
__
InChI key:
__